Introduction
Creatine Kinase (CK) is the enzyme responsible for catalysing the exchange of phosphates in the creatine/phosphocreatine shuttle. 1 Skeletal muscle CK is made up of 90% muscle CK (CK-MM) and 10% heart CK (CK-MB). 2, 3 In muscle damage (e.g. rhabdomyolysis), extreme exercise and statin-induced myositis, serum CK can be raised in excess of 10 times the upper limit of normal. 4 However, the recent discovery of a single nucleotide polymorphism(SNP), rs11559024 in the CKM gene 5 results in an inability to produce skeletal muscle type CK and therefore low levels of CK in clinical scenarios that may result in crucial diagnosis such as rhabdomyolysis and statin-induced myositis being missed.
Case report Further admissions in subsequent years for a hemicolectomy (for bowel cancer) also revealed significant blunting in her expected CK levels post-operatively. Her pre-operative CK of 34 IU/l remained relatively unchanged post-operatively (28 IU/l).
Discussion
As a carrier of two copies of the rare allele at the SNP rs11559024 of her CKM gene, this patient was unable to produce measurable functioning skeletal muscle type CK resulting in consistently low serum CK even following necrotising fasciitis and open surgery. In her past history, the patient was also deemed 'intolerant' to statins and was switched multiple times between different statins. Her CK levels were falsely reassuring when checked by clinicians looking for evidence of a statin-induced myositis.
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